Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Consumer Fraud

A class action filed in Chicago federal court claims that Pfizer misleads consumers with its maximum strength Robitussin, which the lawsuit says contains less cough suppressant and the same amount of expectorant as regular strength.

CHICAGO – A class action filed in Chicago federal court claims that Pfizer misleads consumers with its maximum strength Robitussin, which the lawsuit says contains less cough suppressant and the same amount of expectorant as regular strength.

Categories / Business, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...